DreaMed

Petah Tikva, Israel Founded: 2014 • Age: 12 yrs
Clinical decisions for diabetes management are supported by AI-based system.
Request Access

About DreaMed

DreaMed is a company based in Petah Tikva (Israel) founded in 2014 by Eran Atlas.. DreaMed has raised $8.3 million across 5 funding rounds from investors including Medtronic, eHealth Ventures and Norma Investment. DreaMed offers products and services including endo.digital, Uploader, and Mobile App. DreaMed operates in a competitive market with competitors including Fitterfly, Glytec Systems, Vitadio, Steady Health and Hillo, among others.

  • Headquarter Petah Tikva, Israel
  • Founders Eran Atlas
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.3 M (USD)

    in 5 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Aug 19, 2024

  • Investors
    Medtronic

    & 4 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DreaMed

DreaMed offers a comprehensive portfolio of products and services, including endo.digital, Uploader, and Mobile App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Cloud-based tool for diabetes decision support and data management.

Platform to acquire and upload diabetes device data securely.

App for tracking and managing diabetes events and treatments.

People of DreaMed
Headcount 10-50
Employee Profiles 18
Board Members and Advisors 6
Employee Profiles
People
Noy Ben Moyal
Marketing Director
People
Eran Atlas
Co-founder & CEO
People
Revital Nimri
Co-founder & Chief Medical R&D Officer
People
Paul Schroeder
Vice President BD & Partnerships

Unlock access to complete

Board Members and Advisors
people
Moshe Phillip
Chairman
people
Amir Tirosh
Clinical Advisor
people
Netalie Nadivi
Advisor
people
Kinneret Savitsky
Director

Unlock access to complete

Funding Insights of DreaMed

DreaMed has successfully raised a total of $8.3M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series A — $3.0M
  • First Round

    (06 Apr 2015)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2024 Amount Series A - DreaMed Valuation eHealth Ventures
Sep, 2017 Amount Series A - DreaMed Valuation Medtronic
Jul, 2016 Amount Series A - DreaMed Valuation Roman Abramovich
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in DreaMed

DreaMed has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Medtronic, eHealth Ventures and Norma Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage digital health ventures are funded and supported.
Founded Year Domain Location
-
Founded Year Domain Location
A charitable trust focused on healthcare and research funding.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by DreaMed

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DreaMed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dreamed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DreaMed

DreaMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fitterfly, Glytec Systems, Vitadio, Steady Health and Hillo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A mobile app is offered for managing multiple chronic diseases.
domain founded_year HQ Location
Offers cloud-based SaaS for diabetes management and insulin dosing in hospitals.
domain founded_year HQ Location
Online platform for diabetic patients' management and information is provided.
domain founded_year HQ Location
Diabetes management app is provided to patients by Steady Health.
domain founded_year HQ Location
Provider of clinical decision tool for healthcare professionals
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dreamed

Frequently Asked Questions about DreaMed

When was DreaMed founded?

DreaMed was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is DreaMed located?

DreaMed is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.

Who is the current CEO of DreaMed?

Eran Atlas is the current CEO of DreaMed. They have also founded this company.

Is DreaMed a funded company?

DreaMed is a funded company, having raised a total of $8.3M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3.3M, raised on Apr 06, 2015.

What does DreaMed do?

DreaMed was founded in 2014 in Petah Tikva, Israel, focusing on health technology for diabetes care. An AI-driven clinical decision support system is developed to assist providers. The initial product, Endo.digital, operates as a cloud-based SaaS platform, enabling end-to-end diabetes pathways. Deployment occurs across various care settings, including remote and in-person treatments for patients.

Who are the top competitors of DreaMed?

DreaMed's top competitors include Fitterfly, Vitadio and Steady Health.

What products or services does DreaMed offer?

DreaMed offers endo.digital, Uploader, and Mobile App.

Who are DreaMed's investors?

DreaMed has 5 investors. Key investors include Medtronic, eHealth Ventures, Norma Investment, Roman Abramovich, and Helmsley Charitable Trust.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available